Home ⟩ Insights

Insights

news

2 min read • May 4, 2026

Next Stop, Senate: New Hemp THC Limits Become a Federal Roadblock for the 2026 Farm Bill

5 min read • May 2, 2026

Industry Attorneys Weigh In as Federal Cannabis Rescheduling Heads to June 29 Hearing

3 min read • April 29, 2026

New Lawsuit Claims CMS Medicare Cannabis Program Undermines FDA-Approved Drug Development

stock stocks markets chart psychedelics cannabis

2 min read • April 24, 2026

420 Sales Spike 2.5× in 2026 as Dutchie’s New Dashboard Highlights Deal-Driven Demand

2 min read • April 23, 2026

Medical Cannabis Stocks Volatile on Trump Reclassification Move

2 min read • April 22, 2026

Marijuana Use Under Scrutiny In New Medicaid Cost And Health Impact GOP-Backed Bill

2 min read • April 22, 2026

Cannabis Stocks Surge As Trump Administration Signals Marijuana Reclassification

3 min read • April 21, 2026

Is This Red State Turning Purple? Democrat Gov. Candidate Makes Marijuana Reform A Campaign Issue

cannabis investors rescheduling marijuana

3 min read • April 21, 2026

Missouri Bets On Marijuana Research As It Opens Unlimited Licensing Pathway

2 min read • April 21, 2026

Another State Joins Wave Of Bringing Medical Cannabis Into End-Of-Life Care Amid National Longevity Care Shift

3 min read • April 19, 2026

Cannabis Enters Longevity Care As Oregon Allows Use In Hospice And Palliative Settings

2 min read • April 17, 2026

TerrAscend Recruits This Retail Veteran As New CFO To Support Next Phase Of Growth

Latest Headlines

5 min read • May 9, 2026

DEA Registration, 280E Relief, and State Rules Top Concerns After Rescheduling Order

2 min read • May 8, 2026

Cresco Labs Bets On Cannabis Rescheduling, Q1 Revenue And Profitability Weaken

7 min read • May 8, 2026

Verano CIO Aaron Miles On Margin Compression, Texas Expansion, Schedule III, and Why He Believes Cannabis Is “A Slam Dunk”

5 min read • May 8, 2026

Tilray CEO Says Schedule III Marks A Turning Point For U.S. Medical Cannabis

2 min read • May 7, 2026

Green Thumb Industries Q1 Revenue Rises 7.4% YoY On Strong State Sales, Net Income Doubles

4 min read • May 7, 2026

TerrAscend Reports Q1 2026 Revenue Growth, Positive Free Cash Flow, Net Loss Widens

5 min read • May 7, 2026

ACE Venture Acquires 51% of Vireo New York and Debuts Boukét Brand

2 min read • May 7, 2026

Trulieve Swings To Profit In Q1, Expands Florida Operations As DEA Cannabis Hearing Nears

2 min read • May 7, 2026

Target Bets Big On Hemp Beverages With Rollout In These Three States Despite Regulatory Uncertainty

4 min read • May 7, 2026

Exclusive: Alcohol Industry Tells Congress Its Model Can Support Hemp Regulation

min read • May 7, 2026

Trulieve Cannabis Corp. to Hold First Quarter 2026 Results Conference Call on May 7, 2026

3 min read • May 6, 2026

Federal Tax Guidance for State-Licensed Medical Cannabis Companies Is Coming, Treasury Says

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

hemp legalization

hemp regulation

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.